Natural killer cell function, an important target for infection and tumor protection, is impaired in type 2 diabetes.

por Jeannig Berrou, Sophie Fougeray, Marion Venot, Victor Chardiny, Jean-François Gautier, Nicolas Dulphy, Antoine Toubert, Marie-Noëlle Peraldi
Publicado 2013

Biological Effects of BET Inhibition by OTX015 (MK-8628) and JQ1 in NPM1-Mutated (NPM1c) Acute Myeloid Leukemia (AML)

por Hanane Djamai, Jeannig Berrou, Mélanie Dupont, Marie-Magdelaine Coudé, Marc Delord, Emmanuelle Clappier, Alice Marceau-Renaut, Anna Kaci, Emmanuel Raffoux, Raphaël Itzykson, Caroline Berthier, Hsin-Chieh Wu, Rita Hleihel, Ali Bazarbachi, Hugues de Thé, André Baruchel, Claude Gardin, Hervé Dombret, Thorsten Braun
Publicado 2021